These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 36601912

  • 1. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
    Türkmen H, Uysal F, Bostan ÖM.
    Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
    Fu L, Luo S, Cai S, Hong W, Guo Y, Wu J, Liu T, Zhao C, Li F, Huang H, Huang M, Wang J.
    Am J Cardiol; 2016 Sep 15; 118(6):888-894. PubMed ID: 27460667
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Danon disease as a cause of autophagic vacuolar myopathy.
    Yang Z, Vatta M.
    Congenit Heart Dis; 2007 Sep 15; 2(6):404-9. PubMed ID: 18377432
    [Abstract] [Full Text] [Related]

  • 11. Paediatric hypertrophic cardiomyopathy secondary to Danon disease.
    Tang K, Wu J, Liu X, Wang S.
    Cardiol Young; 2024 Jan 15; 34(1):201-204. PubMed ID: 37990583
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular and histologic insights on early onset cardiomyopathy in Danon disease females.
    Fernández L, Casamayor Polo L, Bravo García-Morato M, Enguita Valls AB, Ruiz-Bravo E, Muñoz-Cabello P, Ibáñez K, Rodríguez-Laguna L, Martín-Arenas R, Ortega M, Palomares-Bralo M, Del Pozo Á, García-Guereta L, García-Miñaúr S, Lapunzina P, Vallespín E.
    Clin Genet; 2021 Mar 15; 99(3):481-483. PubMed ID: 33226119
    [No Abstract] [Full Text] [Related]

  • 18. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
    Jhaveri S, Herber J, Zahka K, Boyle GJ, Saarel EV, Aziz PF.
    J Cardiovasc Electrophysiol; 2019 Oct 15; 30(10):1932-1938. PubMed ID: 31240821
    [Abstract] [Full Text] [Related]

  • 19. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease.
    Kim H, Cho A, Lim BC, Kim MJ, Kim KJ, Nishino I, Hwang YS, Chae JH.
    Muscle Nerve; 2010 Jun 15; 41(6):879-82. PubMed ID: 20513107
    [Abstract] [Full Text] [Related]

  • 20. Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy).
    Samad F, Jain R, Jan MF, Sulemanjee NZ, Menaria P, Kalvin L, Bush M, Jahangir A, Khandheria BK, Tajik AJ.
    Int J Cardiol; 2017 Oct 15; 245():201-206. PubMed ID: 28874292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.